Off the wire
• EU, Malawi sign aid program worth over 500 mln euros  • Nineteen Russian tourists injured in lighting strike on Crete island  • Protesting Croatian war veterans clash with police, leaders call for dialogue  • 2nd LD Writethru: U.S. economy shrinks in Q1 on severe weather  • Xinjiang to have 1,500 bilingual judges before 2020  • Kenya says 85 radicalized youth surrender under amnesty offer  • Merkel not ruling out EU treaty changes after talks with Cameron  • China new rules show mercy to "kin concealment" of illegal gains  • Urgent: U.S. officially removes Cuba from list of state sponsors of terrorism  • North-West Africa gets new financial platform from China  
You are here: 　 Home

Novo Nordisk supports university for student exchange program

Xinhua, May 30, 2015 Adjust font size:

Danish pharmaceutical company Novo Nordisk announced on Friday that it had signed a three-year agreement with the University of Copenhagen on a scholarship program for talented students.

The Novo Nordisk International Program of Talents is aimed at boosting student mobility between the University of Copenhagen and selected partner universities within the International Alliance of Research Universities (IARU), of which the University of Copenhagen is a member, the company said in a statement.

According to the statement, Novo Nordisk will grant up to 5 million Danish kroner annually to the scholarship program, which is set to start in 2015 and will be fully implemented in 2016.

"International talents are vital for Copenhagen as a science metropolis and for Novo Nordisk as a company. We want to encourage Danish students to study more abroad to tap into new knowledge, and we also want more international students to become aware of Denmark as an attractive place of study," said Mads Krogsgaard Thomsen, executive vice president and chief science officer at Novo Nordisk.

He also expressed hope that the agreement will create a stronger, more global and competitive study and research environment in Copenhagen.

Headquartered in Denmark, Novo Nordisk is a healthcare company with some 40,700 employees around the world. It markets its products in more than 180 countries and regions. (1 U.S. dollar = 6.83 Danish kroner) Endit